#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Hereditary neuropathic amyloidosis Acute graft versus host disease in liver Isodicentric chromosome 15 syndrome Iron overload Fontan procedure Piriformis syndrome PIK3CA related overgrowth spectrum Chronic graft versus host disease in liver Cytomegalovirus infection Thyroid cancer metastatic Acute lymphocytic leukaemia recurrent Hereditary angioedema with C1 esterase inhibitor deficiency Plasma cell myeloma Encephalitis autoimmune More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Life with Disease Leiomyosarcoma metastatic Congenital nephrogenic diabetes insipidus – Treatment Medulloblastoma – Treatment Acquired haemophilia – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Pemphigus – Basic Information Idiopathic pulmonary fibrosis – Life with Disease Haemophagocytic lymphohistiocytosis – Basic Information Loeys-Dietz syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rosuvastatin Calcium Omo-103 ADS-019 Interferon Alfa Enasidenib Mesilate Teriparatide Paracetamol Dc Mps-102 Elranatamab ZINC VTX2735 SODIUM Amylase Flecainide Acetate Netupitant Vildagliptin Eptacog Beta (Activated) Ibuprofen Sodium Dihydrate ANX007 Maribavir Fremanezumab More therapies…

    Learn about Your Condition

    Peripheral artery angioplasty Brain neoplasm Netherton's syndrome Combined immunodeficiency Muscle spasticity Lysosomal storage disorder Pelizaeus-Merzbacher disease Epiphysiolysis Optic atrophy Inclusion body myositis Colorectal cancer stage III Squamous cell carcinoma Thalassaemia beta B-cell lymphoma recurrent Glycogen storage disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • A study of psilocybin and psychological support compared to diphenhydramine hydrochloride for people with cocaine addiction

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Ireland
  • Study of pipamperone and aripiprazole for challenging behaviors in people with intellectual disabilities

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Aripiprazole
    The Netherlands
  • Testing the safety and effectiveness of stem cells from fat tissue in children with autism spectrum disorder and digestive problems

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Denmark
  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Escitalopram
    • Fluoxetine
    • Paroxetine
    Spain
  • Study of aldesleukin in children aged 4 to 6 years with autism spectrum disorder whose mothers had immune system activation during pregnancy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Aldesleukin
    France
  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Major depression
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Norway
Previous Page
1 … 23 24 25 26 27 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!